Account
Inquiry
Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications in weight management and type 2 diabetes studies. This synthetic peptide demonstrates superior metabolic effects compared to single receptor agonists.
The mechanism of action involves simultaneous activation of both GIP and GLP-1 receptors, which enhances insulin secretion, reduces glucagon secretion, slows gastric emptying, and promotes satiety. Clinical research shows tirzepatide 15mg may lead to 15-20% body weight reduction over 72 weeks while significantly improving glycemic control.
Our tirzepatide 15mg is supplied as white freeze-dried powder in sterile vials with 99.9% HPLC-verified purity. Each batch undergoes rigorous quality control testing to ensure research-grade standards. The product is packaged with 10 vials per box, with options for custom packaging available for bulk orders.
For laboratory research purposes only. Not for human consumption. Researchers should handle all peptide materials according to proper safety protocols and institutional guidelines.
